FDA approves OVD for use in ophthalmic surgery
Bausch + Lomb’s ClearVisc dispersive ophthalmic viscosurgical device has received FDA approval for use in ophthalmic surgery.
FDA approves topical corticosteroid for treatment of dry eye disease
The FDA has approved loteprednol etabonate ophthalmic suspension 0.25% for short-term treatment of the signs and symptoms of dry eye disease.
Bausch Health: Spin-off of eye health business
This action will result in 2 separate companies,
Ophthalmologist-Mayor Deirdre Waterman on healing a community amid pandemic, protests
Returning to the new ‘norm’ of ophthalmic practice
COVID-19: Keep calm and carry on emotionally and financially
Provider portal offers 60-second benefit verification
Provider portal features an updated enrollment form, and potential for a 60-second benefit verification.
STAAR Surgical announces management additions, promotions
The company promotes two and adds another employee as it names three vice presidents.
UK accepts additional data for DME implant
Pseudophakic patients may benefit from a fluocinolone acetonide intravitreal implant (Iluvien, Alimera Sciences), the company tells a United Kingdom committee.
Cellular-scale retinal camera receives CE mark
A cellular-level adaptive optics retinal camera (rtx1, Imagine Eyes) has received CE mark approval in the European Union.
Sealant being studied for clear corneal wound closure
A new sealant (ReSure, Ocular Therapeutix) will be studied for clear corneal incision closure after cataract extraction or IOL placement.
New drug delivery system aims to increase tissue penetration
Improved efficacy and dosing convenience are the aims of a new drug delivery system incorporating a cationic polymer and formulated with ketorolac.
New data confirm efficacy, safety of ranibizumab
New data presented at the European Society of Retina Specialists meeting suggest that ranibizumab is effective in patients with AMD, DME, and RVO.
Encourage patients with bilateral vision loss to be more active
Newly published research gives ophthalmologists a reason to encourage their adult patients with visual field loss in both eyes to be more physically active.
Cause of cone death discovered in retinitis pigmentosa
Researchers have identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigments (RP).
Wilmer Eye Institute awarded AHAF grants for glaucoma and AMD
Glaucoma and age-related macular degeneration (AMD) research grants have been awarded to Wilmer Eye Institute by the American Health Assistance Foundation.
Welch Allyn facility earns LEED environmental certification
The Welch Allyn facility in Beaverton, OR, earned Leadership in Energy and Environmental Design (LEED) certification from the U.S. Green Building Council.
Moore named Iridex interim president, CEO
William M. Moore has been named interim president and chief executive officer of Iridex Corp. Moore succeeds Dominik Beck.
STAAR Surgical consolidates lens operations in Monrovia, CA
Implantable contact lens and preloaded IOL manufacturing will move to California in a consolidation project now under way at STAAR Surgical.
Glaucoma may be linked to depression
Glaucoma may be a significant predictor of depression, according to research published in the American Journal of Ophthalmology.
FDA clears laser for cataract surgery incisions
The FDA approved OptiMedica's Catalys Precision for creating single-plane and multi-plane arc incisions in the cornea during cataract surgery.
Phase II study for travoprost punctum plugs
Ocular Therapeutix Inc. is initiating a phase II clinical trial of OTX-TP2, a 2-month travoprost punctum plug for treating ocular hypertension and glaucoma.
Gevokizumab receives orphan drug designation
Gevokizumab, an IL-1 beta-modulating antibody from XOMA Corp., has received FDA orphan drug designation for the treatment of several types of non-infectious uveitis.
Laser surgery education gets $1 million boost
Ophthalmologists will have a new way to learn about advances in laser surgery next year, thanks to a $1 million donation made to the American Academy of Ophthalmology.
Retinal disease research gets $2.4 million boost
The Foundation Fighting Blindness is funding projects related to age-related macular degeneration, retinitis pigmentosa, Leber's congenital amaurosis, and Usher syndrome.
JCAHPO taps Pearson VUE to offer simulated exams
The Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) and Pearson VUE partner to provide ophthalmic medical techs access to simulated exams.
Insight Software ranked on Inc. 500|5000 list
Insight Software, creators of My Vision Express, has been ranked by Inc. magazine as one of the nation's fastest-growing private companies.
Enrollment begins for cataract surgery pain trial
Patient enrollment has begun in a phase III clinical trial of a low dose of bromfenac for pain and inflammation reduction after cataract surgery.
September is Sports Eye Injury Awareness Month
Prevent Blindness America (PBA) has designated September as Sports Eye Safety Awareness Month.
Ophthalmologists fare relatively well in survey of physician burnout, work/life balance
Compared to an average of all physicians, ophthalmologists fared slightly better in a survey of physician burnout.
2 Clarke Drive Cranbury, NJ 08512